Carsten Olbrich PhD

Dr. Carsten Olbrich studied Pharmacy at the University of Heidelberg and continued his qualification at the Free University Berlin, completing a Ph.D. in Pharmaceutical Science. The title of his Ph.D. thesis was ‘Optimized lipid nanoparticles and their biological testing’, focusing on nanoparticulate delivery systems for various purposes. Carsten joined Schering AG in 2000 as a Laboratory Head in diagnostic research, working on antibody attachment to surfaces of intravenous injectable polymeric particles, and quality methods for targeting specific imaging agents. In 2004, he joined the Pharmaceutical Development Department, where he acted as Associated Director in the CMC Technology Office and Drug Delivery Systems department as a scout for new technologies for CMC. In 2006, he joined the Parenteral Development Group of Bayer Schering Pharma AG as a director and is now a Senior Scientist in the Liquid Dosage Form development department, where he is responsible for drug products development of parenteral and especially biologicals.